Publications searcher The science produced by our scientists is very important. In 2024, 1,501 papers were published in scientific journals with an average impact factor of over 7.13 points. Fulltext search Alphabetic A-Z Alphabetic Z-A A Phase Ib, open-label, dose-finding study of alpelisib in combination with paclitaxel in patients with advanced solid tumors. PMID: 30167089 Journal: Oncotarget Year: 2018 Reference: Oncotarget. 2018 Aug 3;9(60):31709-31718. doi: 10.18632/oncotarget.25854. eCollection 2018 Aug 3. Impact factor: Publication type: Clinical Trials Authors: Azaro, Analia; Beck, Thaddeus; Curigliano, Giuseppe; Delord, Jean-Pierre; Donnet, Valerie; Han, Yu; Harb, Wael; Rodon, Jordi; Sellami, Dalila; Wilke, Celine et al. DOI: 10.18632/oncotarget.25854 A phase II Study Evaluating Combined Neoadjuvant Cetuximab and Chemotherapy Followed by Chemoradiotherapy and Concomitant Cetuximab in Locoregional Oesophageal Cancer Patients. PMID: 29128908 Journal: Targeted Oncology Year: 2018 Reference: Target Oncol. 2018 Feb;13(1):69-78. doi: 10.1007/s11523-017-0536-z. Impact factor: 3.877 Publication type: Paper in international publication Authors: Alsina, Maria, Rivera, Fernando, Ramos, Francisco Javier, Galan, Maica, Lopez, Rafael, Garcia-Alfonso, Pilar, Ales-Martinez, Jose Enrique, Queralt, Bernardo, Anton, Antonio, Carrato, Alfredo et al. DOI: 10.1007/s11523-017-0536-z A phase II Study Evaluating Combined Neoadjuvant Cetuximab and Chemotherapy Followed by Chemoradiotherapy and Concomitant Cetuximab in Locoregional Oesophageal Cancer Patients. PMID: 29128908 Journal: Targeted Oncology Year: 2018 Reference: Target Oncol. 2018 Feb;13(1):69-78. doi: 10.1007/s11523-017-0536-z. Impact factor: Publication type: Paper in international publication Authors: Ales-Martinez, Jose Enrique; Alsina, Maria; Anton, Antonio; Aranda, Enrique; Carrato, Alfredo; de Mena, Inmaculada Ruiz; Galan, Maica; Garcia-Alfonso, Pilar; Giralt, Jordi; Gravalos, Cristina et al. DOI: 10.1007/s11523-017-0536-z A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia. PMID: 29392425 Journal: ANNALS OF HEMATOLOGY Year: 2018 Reference: Ann Hematol. 2018 May;97(5):763-772. doi: 10.1007/s00277-018-3229-5. Epub 2018 Feb 2. Impact factor: 2.845 Publication type: Paper in international publication Authors: Cordon, Lourdes, Martinez-Cuadron, David, Boluda, Blanca, Martinez, Pilar, Bergua, Juan, Rodriguez-Veiga, Rebeca, Esteve, Jordi, Vives, Susana, Serrano, Josefina, Vidriales, Belen et al. DOI: 10.1007/s00277-018-3229-5 A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia. PMID: 29392425 Journal: ANNALS OF HEMATOLOGY Year: 2018 Reference: Ann Hematol. 2018 May;97(5):763-772. doi: 10.1007/s00277-018-3229-5. Epub 2018 Feb 2. Impact factor: Publication type: Paper in international publication Authors: Benavente, Celina; Bergua, Juan; Boluda, Blanca; Cordon, Lourdes; Diaz-Beya, Marina; Esteve, Jordi; Fernandez, Pau Montesinos; Garrido, Ana; Jimenez-Ubieto, Ana; Martinez, Pilar et al. DOI: 10.1007/s00277-018-3229-5 A Placebo-Controlled Phase II Study of Ruxolitinib in Combination With Pemetrexed and Cisplatin for First-Line Treatment of Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer and Systemic Inflammation. PMID: 29681434 Journal: Clinical Lung Cancer Year: 2018 Reference: Clin Lung Cancer. 2018 Sep;19(5):e567-e574. doi: 10.1016/j.cllc.2018.03.016. Epub 2018 Mar 23. Impact factor: 4.204 Publication type: Paper in international publication Authors: Waqar, Saiama N, Martinez-Marti, Alex, Ponce, Santiago, Zhen, Huiling, Kennealey, Gerard, Erickson-Viitanen, Susan, Schaefer, Eric, Sanborn, Rachel E, Giaccone, Giuseppe et al. DOI: 10.1016/j.cllc.2018.03.016 A Placebo-Controlled Phase II Study of Ruxolitinib in Combination With Pemetrexed and Cisplatin for First-Line Treatment of Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer and Systemic Inflammation. PMID: 29681434 Journal: Clinical Lung Cancer Year: 2018 Reference: Clin Lung Cancer. 2018 Sep;19(5):e567-e574. doi: 10.1016/j.cllc.2018.03.016. Epub 2018 Mar 23. Impact factor: Publication type: Paper in international publication Authors: Erickson-Viitanen, Susan; Giaccone, Giuseppe; Kennealey, Gerard; Martinez-Marti, Alex; Ponce, Santiago; Sanborn, Rachel E; Schaefer, Eric; Waqar, Saiama N; Zhen, Huiling et al. DOI: 10.1016/j.cllc.2018.03.016 A pragmatic approach for mortality prediction after surgery in infective endocarditis: Optimizing and refining EuroSCORE. PMID: 29408350 Journal: CLINICAL MICROBIOLOGY AND INFECTION Year: 2018 Reference: Clin Microbiol Infect. 2018 Oct;24(10):1102.e7-1102.e15. doi: 10.1016/j.cmi.2018.01.019. Epub 2018 Mar 3. Impact factor: 5.394 Publication type: Paper in international publication Authors: Aznar, Maria L, de Alarcon, Aristides, Garcia-Cabrera, Emilio, Galvez-Acebal, Juan, Sanchez-Espin, Gemma, Reguera-Iglesias, Jose M, De La Torre-Lima, Javier, Lomas, Jose M, Hidalgo-Tenorio, Carmen, Vallejo, Nuria et al. DOI: 10.1016/j.cmi.2018.01.019 A pragmatic approach for mortality prediction after surgery in infective endocarditis: Optimizing and refining EuroSCORE. PMID: 29408350 Journal: CLINICAL MICROBIOLOGY AND INFECTION Year: 2018 Reference: Clin Microbiol Infect. 2018 Oct;24(10):1102.e7-1102.e15. doi: 10.1016/j.cmi.2018.01.019. Epub 2018 Mar 3. Impact factor: Publication type: Paper in international publication Authors: Almirante, Benito; Aznar, Maria L; Castro, Miguel A; de Alarcon, Aristides; De La Torre-Lima, Javier; Fernandez-Hidalgo, Nuria; Ferreria-Gonzalez, Ignacio; Galvez-Acebal, Juan; Garcia-Cabrera, Emilio; Garcia-Dorado, David et al. DOI: 10.1016/j.cmi.2018.01.019 A pragmatic approach for mortality prediction after surgery in infective endocarditis: Optimizing and refining EuroSCORE (CLM-17-12757). PMID: 30223027 Journal: CLINICAL MICROBIOLOGY AND INFECTION Year: 2018 Reference: Clin Microbiol Infect. 2018 Dec;24(12):1354. doi: 10.1016/j.cmi.2018.09.002. Epub 2018 Sep 15. Impact factor: 5.394 Publication type: Letter or abstract Authors: Ferreira-Gonzalez, I, Fernandez-Hidalgo, N, Ribera, A et al. DOI: 10.1016/j.cmi.2018.09.002 A pragmatic approach for mortality prediction after surgery in infective endocarditis: Optimizing and refining EuroSCORE (CLM-17-12757). PMID: 30223027 Journal: CLINICAL MICROBIOLOGY AND INFECTION Year: 2018 Reference: Clin Microbiol Infect. 2018 Dec;24(12):1354. doi: 10.1016/j.cmi.2018.09.002. Epub 2018 Sep 15. Impact factor: Publication type: Letter or abstract Authors: Fernandez-Hidalgo, N; Ferreira-Gonzalez, I; Ribera, A et al. DOI: 10.1016/j.cmi.2018.09.002 A Previously Unrecognized Ca(2+)-inhibited Nonselective Cation Channel in Red Blood Cells. PMID: 30887009 Journal: HemaSphere Year: 2018 Reference: Hemasphere. 2018 Oct;2(5):e146. doi: 10.1097/HS9.0000000000000146. Epub 2018 Oct 2. Impact factor: 0 Publication type: Paper in international publication Authors: Petkova-Kirova, Polina, Hertz, Laura, Makhro, Asya, Danielczok, Jens, Huisjes, Rick, Llaudet-Planas, Esther, Manu-Pereira, Maria Del Mar, Vives Corrons, Joan-Luis, van Wijk, Richard, Bogdanova, Anna et al. DOI: 10.1097/HS9.0000000000000146 A Previously Unrecognized Ca(2+)-inhibited Nonselective Cation Channel in Red Blood Cells. PMID: 30887009 Journal: HemaSphere Year: 2018 Reference: Hemasphere. 2018 Oct;2(5):e146. doi: 10.1097/HS9.0000000000000146. Epub 2018 Oct 2. Impact factor: Publication type: Paper in international publication Authors: Bogdanova, Anna; Danielczok, Jens; Hertz, Laura; Huisjes, Rick; Kaestner, Lars; Llaudet-Planas, Esther; Makhro, Asya; Manu-Pereira, Maria Del Mar; Petkova-Kirova, Polina; van Wijk, Richard et al. DOI: 10.1097/HS9.0000000000000146 A prospective international observational prevalence study on prone positioning of ARDS patients: the APRONET (ARDS Prone Position Network) study. PMID: 29218379 Journal: INTENSIVE CARE MEDICINE Year: 2018 Reference: Intensive Care Med. 2018 Jan;44(1):22-37. doi: 10.1007/s00134-017-4996-5. Epub 2017 Dec 7. Impact factor: 15.008 Publication type: Paper in international publication Authors: Durand, Michel, Assiri, A H, Mainas, E, Hasan, M S, Morocho-Tutillo, D R, Baboi, L, Chretien, J M, Francois, G, Ayzac, L, Chen, L et al. DOI: 10.1007/s00134-017-4996-5 A prospective international observational prevalence study on prone positioning of ARDS patients: the APRONET (ARDS Prone Position Network) study. PMID: 29218379 Journal: INTENSIVE CARE MEDICINE Year: 2018 Reference: Intensive Care Med. 2018 Jan;44(1):22-37. doi: 10.1007/s00134-017-4996-5. Epub 2017 Dec 7. Impact factor: Publication type: Paper in international publication Authors: Adam, J F; Al Bshabshe, Ali; Alban, Laura; Albiero, Daniela; Almekhlafi, Ghaleb; Alqdah, M; Amal, Jean-Michel; Anwar, Sibs; Araujo, Ana Carolina; Arbelot, Charlotte et al. DOI: 10.1007/s00134-017-4996-5 A questionnaire survey of radiological diagnosis and management of renal dysplasia in children. PMID: 28647851 Journal: JOURNAL OF NEPHROLOGY Year: 2018 Reference: J Nephrol. 2018 Feb;31(1):95-102. doi: 10.1007/s40620-017-0417-7. Epub 2017 Jun 24. Impact factor: 2.724 Publication type: Paper in international publication Authors: Montini, Giovanni, Busutti, Marco, Yalcinkaya, Fatos, Woolf, Adrian S, Weber, Stefanie, Alpay, Harika, Ariceta, Gema, Bael, An, Bonthuis, Marjolein, Caliskan, Salim et al. DOI: 10.1007/s40620-017-0417-7 A questionnaire survey of radiological diagnosis and management of renal dysplasia in children. PMID: 28647851 Journal: JOURNAL OF NEPHROLOGY Year: 2018 Reference: J Nephrol. 2018 Feb;31(1):95-102. doi: 10.1007/s40620-017-0417-7. Epub 2017 Jun 24. Impact factor: Publication type: Paper in international publication Authors: Alpay, Harika; Antic, Amira Peco; Ariceta, Gema; Bael, An; Bonthuis, Marjolein; Busutti, Marco; Caliskan, Salim; Gotsiridze, Elene; Gulleroglu, Kaan; Gunduz, Zubeyde et al. DOI: 10.1007/s40620-017-0417-7 A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation. PMID: 30377213 Journal: EMBO Molecular Medicine Year: 2018 Reference: EMBO Mol Med. 2018 Dec;10(12). pii: emmm.201809172. doi: 10.15252/emmm.201809172. Impact factor: 10.293 Publication type: Paper in international publication Authors: Vidal, Marc, Peg, Vicente, Serres-Creixams, Xavier, Dellaire, Graham, Simard, Jacques, Nuciforo, Paolo, Rubio, Isabel T, Dientsmann, Rodrigo, Barrett, J Carl, Caldas, Carlos et al. DOI: 10.15252/emmm.201809172 A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation. PMID: 30377213 Journal: EMBO Molecular Medicine Year: 2018 Reference: EMBO Mol Med. 2018 Dec;10(12). pii: emmm.201809172. doi: 10.15252/emmm.201809172. Impact factor: Publication type: Paper in international publication Authors: Balmana, Judith; Barrett, J Carl; Baselga, Jose; Bonache, Sandra; Bruna, Alejandra; Cairo, Stefano; Caldas, Carlos; Castroviejo-Bermejo, Marta; Cortes, Javier; Cruz, Cristina et al. DOI: 10.15252/emmm.201809172 A randomized phase II study evaluating different maintenance schedules of nab-paclitaxel in the first-line treatment of metastatic breast cancer: final results of the IBCSG 42-12/BIG 2-12 SNAP trial. PMID: 29228091 Journal: ANNALS OF ONCOLOGY Year: 2018 Reference: Ann Oncol. 2018 Mar 1;29(3):661-668. doi: 10.1093/annonc/mdx772. Impact factor: 13.926 Publication type: Clinical guide Authors: Gennari, A, Sun, Z, Hasler-Strub, U, Colleoni, M, Kennedy, M J, Von Moos, R, Cortes, J, Vidal, M J, Hennessy, B, Walshe, J et al. DOI: 10.1093/annonc/mdx772 A randomized phase II study evaluating different maintenance schedules of nab-paclitaxel in the first-line treatment of metastatic breast cancer: final results of the IBCSG 42-12/BIG 2-12 SNAP trial. PMID: 29228091 Journal: ANNALS OF ONCOLOGY Year: 2018 Reference: Ann Oncol. 2018 Mar 1;29(3):661-668. doi: 10.1093/annonc/mdx772. Impact factor: Publication type: Clinical guide Authors: Barbeaux, A; Bernhard, J; Borstnar, S; Colleoni, M; Cortes, J; Gennari, A; Hasler-Strub, U; Hennessy, B; Jerusalem, G; Kennedy, M J et al. DOI: 10.1093/annonc/mdx772 A rare cause of primary adrenal insufficiency due to a homozygous Arg188Cys mutation in the STAR gene. PMID: 29576868 Journal: Endocrinology, diabetes & metabolism case repo Year: 2018 Reference: Endocrinol Diabetes Metab Case Rep. 2018 Mar 21;2018. pii: EDM180003. doi: 10.1530/EDM-18-0003. eCollection 2018. Impact factor: 0 Publication type: Paper in international publication Authors: Henzen, Christoph, Burget, Lukas, Parera, Laura Audi, Fernandez-Cancio, Monica, Grani, Rolf, Fluck, Christa E et al. DOI: 10.1530/EDM-18-0003 A rare cause of primary adrenal insufficiency due to a homozygous Arg188Cys mutation in the STAR gene. PMID: 29576868 Journal: Endocrinology, diabetes & metabolism case repo Year: 2018 Reference: Endocrinol Diabetes Metab Case Rep. 2018 Mar 21;2018. pii: EDM180003. doi: 10.1530/EDM-18-0003. eCollection 2018. Impact factor: Publication type: Paper in international publication Authors: Burget, Lukas; Fernandez-Cancio, Monica; Fluck, Christa E; Grani, Rolf; Henzen, Christoph; Parera, Laura Audi et al. DOI: 10.1530/EDM-18-0003 A retrospective, multicentre study of perampanel given as monotherapy in routine clinical care in people with epilepsy. PMID: 29288911 Journal: SEIZURE-EUROPEAN JOURNAL OF EPILEPSY Year: 2018 Reference: Seizure. 2018 Jan;54:61-66. doi: 10.1016/j.seizure.2017.10.015. Epub 2017 Oct 18. Impact factor: 2.839 Publication type: Paper in international publication Authors: Gil-Nagel, Antonio, Burd, Sergey, Toledo, Manuel, Sander, Josemir W, Lebedeva, Anna, Patten, Anna, Laurenza, Antonio et al. DOI: 10.1016/j.seizure.2017.10.015 Pagination First page « First Previous page ‹ Previous … Page 812 Page 813 Page 814 Page 815 Current page 816 Page 817 Page 818 Page 819 Page 820 … Next page Next › Last page Last »
